Armistice Capital, LLC Vanda Pharmaceuticals Inc. Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $30.8 Million - $41.5 Million	-1,965,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $11.5 Million - $15.9 Million	-749,000 Reduced 27.6%	1,965,000 $33.7 Million
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $17 Million - $23.3 Million	-1,082,000 Reduced 28.5%	2,714,000 $58.4 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $21.5 Million - $32.5 Million	-1,603,277 Reduced 29.69%	3,796,000 $57 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $495,563 - $700,484	-50,723 Reduced 0.93%	5,399,277 $70.9 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $6.06 Million - $7.81 Million	650,000 Added 13.54%	5,450,000 $52.6 Million
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $2.24 Million - $2.79 Million	232,000 Added 5.08%	4,800,000 $54.9 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $13.1 Million - $29.2 Million	1,740,000 Added 61.53%	4,568,000 $47.3 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $8.91 Million - $12.6 Million	-720,000 Reduced 20.29%	2,828,000 $46.4 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $4.79 Million - $6.16 Million	390,000 Added 12.35%	3,548,000 $47.1 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $42.2 Million - $59.5 Million	3,158,000 New	3,158,000 $44.5 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $17.1 Million - $28.3 Million	-900,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $24.2 Million - $30.5 Million	-1,324,000 Reduced 59.53%	900,000 $20.7 Million
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $5.25 Million - $7.2 Million	-376,000 Reduced 14.46%	2,224,000 $42.4 Million
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $1.1 Million - $1.58 Million	-78,000 Reduced 2.91%	2,600,000 $43.8 Million
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $14.7 Million - $20.7 Million	1,146,000 Added 74.8%	2,678,000 $40.7 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $23.6 Million - $28.9 Million	1,532,000	1,532,000 $27.4 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$37.4 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$18.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$16.7 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.8 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$10.4 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $260M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account